📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: H-Immune

1.1 - Company Overview

H-Immune Logo

H-Immune

Headquarter: France
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of early-stage biopharmaceutical research and development, utilizing an immunotherapeutic approach to create novel, fully human antibody-based blockade therapeutics aimed at generating new immuno-oncology treatments for cancer.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to H-Immune

Cargo Therapeutics Logo

Cargo Therapeutics

HQ: United States Website
  • Description: Provider of CAR T-cell therapies and platforms to overcome cancer treatment resistance and address access barriers. Products include CRG-022 (Firi-cel), a CD22-targeted CAR T for large B-cell lymphoma refractory or relapsed after CD19 CAR T; CRG-023, a tri-specific CAR T targeting CD19/CD20/CD22 with CD2 co-stimulation; a CD2 platform for activation in CD58-lacking tumors; and the STASH platform for multi-gene CAR T engineering.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cargo Therapeutics company profile →
AdnaGen Logo

AdnaGen

HQ: Germany Website
  • Description: Provider of molecular genetic diagnostic testing systems for medical and clinical research laboratories, offering AdnaTest kits with reagents for immunomagnetic selection, mRNA isolation, and multiplex RT-PCR for tumor diagnostics, and focusing on genetic pre-disposition.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AdnaGen company profile →
RadiaDyne Logo

RadiaDyne

HQ: United States Website
  • Description: Provider of medical diagnostics and devices; privately held.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full RadiaDyne company profile →
Cullinan Therapeutics Logo

Cullinan Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage oncology therapeutics, including zipalertinib (CLN-081/TAS6417) for NSCLC with EGFR exon 20 insertion mutations in pivotal Phase 2b; CLN-619, an anti-MICA/B antibody tested with a checkpoint inhibitor for advanced solid tumors and multiple myeloma; CLN-049 for relapsed/refractory AML and MDS in Phase 1; and CLN-617, a collagen-binding IL-12/IL-2 fusion for advanced solid tumors, both as monotherapy and in combination with pembrolizumab.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cullinan Therapeutics company profile →
Advanced Accelerator Applications Logo

Advanced Accelerator Applications

HQ: France Website
  • Description: Provider of targeted radioligand therapies and precision imaging radioligands, offering LUTATHERA: a radioligand therapy using lutetium Lu 177 dotatate for treating tumors; PLUVICTO: a therapeutic radioligand containing lutetium Lu 177 vipivotide tetraxetan; diagnostic PET imaging kits NETSPOT, LOCAMETZ, and SOMAKIT TOC; and LysaKare to reduce renal radiation exposure during peptide-receptor radionuclide therapy with LUTATHERA.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Advanced Accelerator Applications company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for H-Immune

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to H-Immune

2.2 - Growth funds investing in similar companies to H-Immune

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for H-Immune

4.2 - Public trading comparable groups for H-Immune

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to H-Immune

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About H-Immune

What does H-Immune do?

H-Immune is a provider of early-stage biopharmaceutical research and development, utilizing an immunotherapeutic approach to create novel, fully human antibody-based blockade therapeutics aimed at generating new immuno-oncology treatments for cancer.

Who are H-Immune's competitors?

H-Immune's competitors and similar companies include Cargo Therapeutics, AdnaGen, RadiaDyne, Cullinan Therapeutics, and Advanced Accelerator Applications.

Where is H-Immune headquartered?

H-Immune is headquartered in France.

How many employees does H-Immune have?

H-Immune has 1,000 employees 🔒.

When was H-Immune founded?

H-Immune was founded in 2010 🔒.

What sector and industry vertical is H-Immune in?

H-Immune is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for H-Immune

Who are the top strategic acquirers in H-Immune's sector and industry

Top strategic M&A buyers and acquirers in H-Immune's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for H-Immune?

Top strategic M&A buyers groups and sectors for H-Immune include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in H-Immune's sector and industry vertical

Which are the top PE firms investing in H-Immune's sector and industry vertical?

Top PE firms investing in H-Immune's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in H-Immune's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in H-Immune's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in H-Immune's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to H-Immune include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in H-Immune's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for H-Immune?

The key public trading comparables and valuation benchmarks for H-Immune include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for H-Immune for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for H-Immune with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in H-Immune's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for H-Immune with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in H-Immune's' sector and industry vertical?

Access recent funding rounds and capital raises in H-Immune's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for H-Immune